Table 2.
Cohort | Sample size | Number of definite clinical FTD cases identified | Notes |
---|---|---|---|
| |||
ACT | 863 | 0 | |
CC75C | 228 | 0 | Ascertained by post-mortem clinical consensus |
CFAS | 510 | 0 | Ascertained by post-mortem clinical consensus; 2 with “lobar atrophy” |
Duke ADRC | 109 | 0 | |
HAAS | 321 | 0 | |
Mayo/MCSA | 209 | 0 | |
The 90 + Study (UC Irvine) | 402 | 0 | 2 “possible” bvFTD, 1 turned out to have AD, the other vascular pathology |
Uky ADRC | 318 | 0 | |
VITA | 307 | 0 | |
Total number with clinical workup | 3267 | ||
Total number of definite clinical FTD cases identified | 0 |